Management of rare primary liver cancers: combined hepato-cholangiocarcinoma and fibrolamellar hepatocellular carcinoma.
- DOI
- 10.1016/j.jhepr.2026.101991
- Published
- 2026 Aug 13
- Container
- JHEP reports : innovation in hepatology
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jhepr.2026.101991,
title = {Management of rare primary liver cancers: combined hepato-cholangiocarcinoma and fibrolamellar hepatocellular carcinoma.},
author = {Gallant M and Decraecker M and Ziol M and Calderaro J and Ronot M and Zucman-Rossi J and Nault JC},
year = {2026},
journal = {JHEP reports : innovation in hepatology},
doi = {10.1016/j.jhepr.2026.101991},
url = {https://doi.org/10.1016/j.jhepr.2026.101991}
}RIS
TY - JOUR TI - Management of rare primary liver cancers: combined hepato-cholangiocarcinoma and fibrolamellar hepatocellular carcinoma. AU - Gallant M AU - Decraecker M AU - Ziol M AU - Calderaro J AU - Ronot M AU - Zucman-Rossi J AU - Nault JC PY - 2026 JO - JHEP reports : innovation in hepatology DO - 10.1016/j.jhepr.2026.101991 UR - https://doi.org/10.1016/j.jhepr.2026.101991 ER -
APA
M, G., M, D., M, Z., J, C., M, R., J, Z., & JC, N. (2026). Management of rare primary liver cancers: combined hepato-cholangiocarcinoma and fibrolamellar hepatocellular carcinoma.. JHEP reports : innovation in hepatology. https://doi.org/10.1016/j.jhepr.2026.101991
Source records
- pubmed · retrieved 2026-09-27T06:26:12.823Z
- europe-pmc · retrieved 2026-09-27T06:26:12.824Z